Letter/Comment
The latest advocacy letters and comments from the 黑料正能量 Association.
The AHA recognizes that SAMHSA is statutorily constrained in making structural amendments to the regulations under 42 CFR Part 2; however, because the proposed rule would not change the basic framework of Part 2, which significantly impedes the robust sharing of patient information necessary for鈥
The AHA urges Senate appropriators to support federal funding for research and education to reduce violence in communities
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
The AHA appreciates the opportunity to comment on the Drug Enforcement Administration鈥檚 proposed notice on aggregate production quotas for schedule I and II controlled substances.
AHA's input on the Health Resources and Services Administration鈥檚 Rural Access to Health Care Services request for information (RFI). The RFI solicits comments on access to care in rural areas.
AHA urges the Medicare Payment Advisory Commission to release a 鈥渕ore granular assessment of the hospital-level impacts鈥 of its potential changes to the Indirect Medical Education program.
In a letter to Representatives Peter Welch and David B. McKinley:The AHA expresses support for H.R. 4538, the Closing Loopholes for Orphan Drugs Act.
The AHA appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services鈥 hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2020.
The AHA supports a number of proposed policy changes that ensure access to care, support public health efforts, improve quality and promote regulatory relief. Specifically, we strongly support CMS鈥檚 proposed reversal of its previously finalized policies for evaluation and management payments.
The AHA expressed concerns with the Fairness for High-Skilled Immigrants Act (S. 386/H.R.1044), legislation that would eliminate the per-country cap for immigrant visas.